Table 4 Univariate and multivariate analysis of factors associated with overall survival in 114 laryngeal cancer patients

Age

0.928 (0.386–2.233)

0.868

2.440

0.118

Gender

1.857 (0.248–13.910)

0.547

2.856

0.091

T stage

8.280 (2.408–28.478)

0.001*

5.624 (1.594–19.840)

0.007*

N stage

2.229 (0.910–5.461)

0.080

0.081

0.776

M stage

3.935 (1.418–10.917)

0.009*

2.744 (0.987–7.629)

0.053

Clinical stage

6.252 (1.827–21.396)

0.004*

0.398

0.528

Relapse

3.377 (1.395–8.175)

0.007*

2.153

0.142

Thyroid cartilage invasion

4.005 (1.634–9.819)

0.002*

0.699

0.403

CD44

5.845 (1.936–17.647)

0.002*

1.459

0.227

CD133

3.769 (1.436–9.891)

0.007*

0.626

0.429

PLOD2

6.720 (2.193–20.588)

0.001*

4.559 (1.356–15.325)

0.014*